Invention Grant
US08410134B2 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators
失效
8-氧 - 喹啉衍生物作为缓激肽B2受体调节剂
- Patent Title: 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators
- Patent Title (中): 8-氧 - 喹啉衍生物作为缓激肽B2受体调节剂
-
Application No.: US12532703Application Date: 2008-03-22
-
Publication No.: US08410134B2Publication Date: 2013-04-02
- Inventor: Christoph Gibson , Thomas Tradler , Karsten Schnatbaum , Jochen Pfeifer , Elsa Locardi , Dirk Scharn , Matthias Paschke , Ulf Reimer , Uwe Richter , Gerd Hummel , Ulrich Reineke
- Applicant: Christoph Gibson , Thomas Tradler , Karsten Schnatbaum , Jochen Pfeifer , Elsa Locardi , Dirk Scharn , Matthias Paschke , Ulf Reimer , Uwe Richter , Gerd Hummel , Ulrich Reineke
- Applicant Address: DE Berlin
- Assignee: Shire Orphan Therapies GmbH
- Current Assignee: Shire Orphan Therapies GmbH
- Current Assignee Address: DE Berlin
- Agency: Morse, Barnes-Brown & Pendleton, P.C.
- Agent Lisa M. Treannie, Esq.
- Priority: EP07006089 20070323
- International Application: PCT/EP2008/002316 WO 20080322
- International Announcement: WO2008/116620 WO 20081002
- Main IPC: A61K31/04
- IPC: A61K31/04 ; C07D215/38
Abstract:
The present invention is related to compound of the formula (I): or a pharmacologically acceptable salt, solvate, or hydrate thereof, wherein A is a 6-membered heteroaryl having from 1 to 3 heteroatoms, each independently selected from N or O and the other substituents are defined as in the claims.
Public/Granted literature
- US20100234344A1 8-OXY-QUINOLINE DERIVATIVES AS BRADYKININ B2 RECEPTOR MODULATORS Public/Granted day:2010-09-16
Information query
